Surgical Controversies in Advanced Ovarian Cancer

Bradley J. Monk, MD, FACS, FACOG; Thomas Herzog, MD; Kathleen Moore, MD; Leslie M. Randall, MD, MAS; and Oliver Dorigo, MD, PhD, debate among debulking strategies and neoadjuvant therapy in newly diagnosed advanced ovarian cancer based on evidence from the JCOG0602 trial.

• カテゴリー